000 | 00969 a2200301 4500 | ||
---|---|---|---|
005 | 20250513211031.0 | ||
264 | 0 | _c20000725 | |
008 | 200007s 0 0 eng d | ||
022 | _a0012-6667 | ||
024 | 7 |
_a10.2165/00003495-200059040-00007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aClemett, D | |
245 | 0 | 0 |
_aLinezolid. _h[electronic resource] |
260 |
_bDrugs _cApr 2000 |
||
300 |
_a815-27; discussion 828 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAcetamides _xadverse effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBacteria _xdrug effects |
650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLinezolid |
650 | 0 | 4 |
_aOxazoles _xadverse effects |
650 | 0 | 4 | _aOxazolidinones |
700 | 1 | _aMarkham, A | |
773 | 0 |
_tDrugs _gvol. 59 _gno. 4 _gp. 815-27; discussion 828 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003495-200059040-00007 _zAvailable from publisher's website |
999 |
_c10755929 _d10755929 |